ED Coding & Reimbursement Alert - 2015 Issue 15
What the OIG is Scrutinizing Regarding Medicare Part D Billing
Subscribe or sign in to view the full article.
Article Overview
This article summarizes an HHS Office of Inspector General look at Medicare Part D billing patterns, including concern areas tied to prescription drug spending and pharmacies flagged for questionable billing. It is useful for compliance, auditing, pharmacy, and revenue cycle audiences that monitor Part D program integrity, fraud risk, and oversight developments.
Why This Topic Matters
Understanding OIG program-integrity focus areas helps organizations track compliance risks, identify billing patterns that may draw scrutiny, and stay current on Medicare Part D oversight trends.
What You Will Learn
- What the OIG report is examining in Medicare Part D billing
- Why opioid-related spending trends are being highlighted
- How the article frames fraud and abuse concerns in Part D program integrity
- Which OIG reports are referenced for further reading
Who Should Read This
- Compliance professionals
- Medical coders
- Billing staff
- Pharmacy billing teams
- Revenue cycle teams
- Auditors
- Healthcare administrators
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com